Quarterly report pursuant to Section 13 or 15(d)

Stock-based Compensation (Tables)

v3.23.2
Stock-based Compensation (Tables)
6 Months Ended
Jul. 02, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Total Stock-based Compensation Expense
The following table summarizes the total stock-based compensation expense, by operating expense category, recognized in the Condensed Consolidated Statements of Operations for the periods presented below (in thousands).
Quarters Ended Fiscal Years-to-Date Ended
July 2, 2023 July 3, 2022 July 2, 2023 July 3, 2022
Cost of revenue $ 1,654  $ 250  $ 2,605  $ 250 
Research and development 5,456  3,821  17,123  6,333 
Selling, general and administrative 7,932  4,109  24,471  6,835 
Total stock-based compensation expense $ 15,042  $ 8,180  $ 44,199  $ 13,418 
Schedule of Stock Option Activity
The following table summarizes stock option activities for the fiscal year-to-date ended July 2, 2023 (in thousands, except share and per share amount).
Number of
Options
Outstanding
Weighted
Average
Exercise
Price
Weighted
Average
Remaining
Contractual
Life (Years)
Aggregate
Intrinsic
Value (1) (2)
Balances as of January 1, 2023 5,034,282 $ 9.07 
Exercised (180,575) 5.38  $ 1,570 
Forfeited (428,693) 9.69 
Balances as of July 2, 2023 4,425,014 $ 9.17  7.7 $ 39,584 
(1) The intrinsic value of options exercised is based upon the value of the Company’s stock at exercise.
(2)
The aggregate intrinsic value of the stock options outstanding as of July 2, 2023 represents the value of the Company’s closing stock price at $18.04 on July 2, 2023 in excess of the exercise price multiplied by the number of options outstanding.
Schedule of RSUs and PRSUs Activity
The following table summarizes RSUs and PRSUs activities for the fiscal year-to-date ended July 2, 2023 (in thousands, except share and per share amount).
RSUs PRSUs
Number of
Shares
Outstanding
Weighted Average
Grant Date Fair Value
Number of
Shares
Outstanding
Weighted Average
Grant Date Fair Value
Issued and unvested shares balances as of January 1, 2023 5,910,097  $ 14.11  1,461,061  $ 13.41 
Granted 8,950,531  10.65  769,006  13.13 
Vested (1,289,924) 13.08  (166,716) 13.41 
Forfeited (548,343) 13.32  (1,187,540) 13.41 
Issued and unvested shares outstanding as of July 2, 2023 13,022,361  $ 11.86  875,811  $ 13.17